Novo Nordisk

Novo Nordisk UK is the British subsidiary of the Danish pharmaceutical company and global leader in diabetes care, obesity treatment, and rare blood disorders. Key products include Ozempic and Rybelsus (semaglutide) for type 2 diabetes, Wegovy (semaglutide) for chronic weight management, Saxenda (liraglutide) for obesity, Tresiba and Levemir insulins, and NovoSeven for haemophilia.

Novo Nordisk

How to Contact Novo Nordisk

Browse Medications Manufactured by Novo Nordisk

Experienced a Side Effect?

Report to

👉
Yellowcard logo
(UK)
👉
Medwatch logo
(US)
NowPatient - Report Side Effects to Yellow Card or MedWatch